Pro: use of colloids in cardiac surgery.

[1]  J. Boldt.  DO PLASMA SUBSTITUTES HAVE ADDITIONAL PROPERTIES BEYOND CORRECTING VOLUME DEFICITS? , 2006, Shock.

[2]  S. Kozek-Langenecker,et al.  Effects of Hydroxyethyl Starch Solutions on Hemostasis , 2005, Anesthesiology.

[3]  L. Brochard,et al.  Preferred plasma volume expanders for critically ill patients: results of an international survey , 2004, Intensive Care Medicine.

[4]  Jeana E. Havidich,et al.  Why the Food and Drug Administration changed the warning label for hetastarch. , 2004, Anesthesiology.

[5]  A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit , 2004 .

[6]  J. Boldt,et al.  Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. , 2003, Anesthesia and analgesia.

[7]  C. Geisen,et al.  Large-dose Hydroxyethyl Starch 130/0.4 Does Not Increase Blood Loss and Transfusion Requirements in Coronary Artery Bypass Surgery Compared with Hydroxyethyl Starch 200/0.5 at Recommended Doses , 2003, Anesthesiology.

[8]  J. Elefteriades,et al.  Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. , 2003, Chest.

[9]  F. Bepperling,et al.  The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment , 2002, Anesthesia and analgesia.

[10]  R. Strauss,et al.  A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch , 2002, Transfusion.

[11]  J. Boldt,et al.  Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. , 2001, Anesthesia and analgesia.

[12]  W. Sibbald,et al.  Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. , 2001, The Annals of thoracic surgery.

[13]  E. de Jonge,et al.  Effects of different plasma substitutes on blood coagulation: A comparative review , 2001, Critical care medicine.

[14]  B. Gustorff,et al.  The Effects of Hydroxyethyl Starches of Varying Molecular Weights on Platelet Function , 2001, Anesthesia and analgesia.

[15]  J. Boldt,et al.  Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. , 2001, Journal of cardiothoracic and vascular anesthesia.

[16]  L. Brochard,et al.  Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study , 2001, The Lancet.

[17]  W. van Oeveren,et al.  A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[18]  D. Wambold,et al.  Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation. , 1998, Journal of clinical anesthesia.

[19]  R. Wenzel,et al.  The Epidemiology of Hemorrhage Related to Cardiothoracic Operations , 1998, Infection Control & Hospital Epidemiology.

[20]  J. Treib,et al.  Coagulation Disorders Caused by Hydroxyethyl Starch , 1997, Thrombosis and Haemostasis.

[21]  P. Coriat,et al.  Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients , 1996, The Lancet.

[22]  E. Thervet,et al.  Hydroxyethylstarch and osmotic-nephrosis- like lesions in kidney transplantation , 1993, The Lancet.

[23]  E. Moore,et al.  Coagulation changes after albumin resuscitation , 1981, Critical care medicine.

[24]  D. Campbell,et al.  The effect of intravenously administered albumin on dogs with pulmonary interstitial edema. , 1973, Surgery, gynecology & obstetrics.

[25]  E. Bennett-Guerrero,et al.  A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. , 2002, Journal of cardiothoracic and vascular anesthesia.

[26]  A. Pope,et al.  Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries , 1999 .

[27]  P. Dodek,et al.  Distribution of normal saline and 5% albumin infusions in septic patients. , 1999, Critical care medicine.

[28]  M. J. Sanfelippo,et al.  Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. , 1987, American journal of clinical pathology.